This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search
Menu
Close
Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

You are now leaving PfizerPro You are now leaving www.pfizerpro.co.uk and will be directed to our provider, Vistream, to complete your registration. Any personal information that you may find pre-populated from your PfizerPro profile, or you may provide, will be governed by our Privacy Policy. Your data will not be used by Vistream for any other purpose.

PP-UNP-GBR-5079. June 2023
High-risk COVID-19 patients: who are they and how do we find them?

Prescribing information can be found at the bottom of the page. 

Join us on 24 November 2025 to hear from Lana Goodwin. Matron for COVID & OPAT services ANP, discussing 'High-risk COVID-19 patients: who are they and how do we find them?'  followed by a live interactive Q&A. 

Prescribing information can be found at the bottom of the page. 

Join us on 24 November 2025 to hear from Lana Goodwin. Matron for COVID & OPAT services ANP, discussing 'High-risk COVID-19 patients: who are they and how do we find them?'  followed by a live interactive Q&A. 

Event Date24 November 2025 12:20 GMTDuration55 Mins AudienceNurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 12:15 - 12:20Joining & Registration
12:20 - 12:25Welcome & Introduction Avni Dudhia, Pfizer Ltd
12:25 - 13:00High-risk COVID-19 patients: who are they and how do we find them? Lana Goodwin
13:00 - 13:15Questions & Answers Lana Goodwin
13:15Meeting Close
Speakers
Event Speakers
Lana Goodwin
Lana GoodwinMatron for COVID & OPAT services ANP , Mid and South Essex NHS Foundation Trust

No Biography Available

Paxlovid®(nirmatrelvir/ritonavir)

Prescribing Information

Paxlovid®(nirmatrelvir/ritonavir) has a Conditional Marketing Authorisation (CMA) in the United Kingdom. A Conditional Marketing Authorisation means that further evidence on this medicinal product is awaited. New information on this medicinal product will be reviewed when any relevant information of significance becomes available and at least every year and the product information will be updated as necessary.1 

References: 1PAXLOVID UK Summary of Product Characteristics. Pfizer Inc.

Adverse events should be reported. Reporting forms and information can be found at coronavirus-yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-C1D-GBR-0872.  October 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024.

YesNo
You are now leaving PfizerPro​​​​​

You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.

PP-UNP-GBR-12070. April 2025​​​​​​​
​​​​​​​
You are now leaving PfizerPro

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer's medicines or business which it has provided or reviewed.

PP-UNP-GBR-12107. April 2025
​​​​​​​